Private Practices vs Health Systems: Which to Sell First?
Private practices close in weeks, on a check the person you're already talking to can approve. Health systems close in quarters — sometimes a year or more — after a group you've never met reviews your security posture, your data handling, and a contract your champion doesn't control. Neither buyer is "better." The right first customer is whichever one your product can actually serve without help it doesn't have yet.
Quick answer: Default to private practices as your beachhead. A solo physician or small group can trial your product, sign, and pay without a procurement process, which gives you faster feedback and real revenue while you're still figuring out the product. Go straight to health systems only if your product literally can't function at private-practice scale — deep EHR integration, PHI at volume, or value that only shows up across a whole system's patient panel.
That's a beachhead decision in the sense Geoffrey Moore describes in Crossing the Chasm: pick one market segment narrow enough to dominate completely, use it to build reference customers and a working product, then move into the next adjacent segment on the strength of that proof — rather than trying to serve every segment's buyer at once. Private practice and health system aren't two versions of the same buyer; they're two different chasms, and most healthcare startups only have the runway to cross one first. If you haven't mapped the fuller cast of provider, patient, and payer buyers your product might eventually touch, Provider, Patient, or Payer: Who Pays for Digital Health? is the pillar piece this comparison sits under.
Private Practice vs. Health System, Side by Side
The two buyer types differ on nearly every axis that determines how fast you get paid and how much work it costs you to get there. The table below compares them across the five dimensions that matter most when you're choosing a first customer.
| Dimension | Private Practice | Health System |
|---|---|---|
| Sales cycle | Days to a few weeks | Multiple quarters, often a year or more |
| Typical deal size | Small — often a single monthly seat or per-provider fee | Large — enterprise-wide contract, frequently well into six figures annually |
| Decision process | One or two people: the physician-owner and/or office manager | Committee: clinical champion, IT security, legal, procurement, sometimes a C-suite sponsor |
| Integration demands | Often none required to start — a standalone tool is fine | Deep EHR integration, SSO, and audit logging are usually table stakes |
| Churn risk | Higher — one bad quarter, one departing physician, or one price increase can lose the account | Lower once live — switching costs and multi-year contracts make an installed system sticky |
Read across that table and a pattern emerges: everything that makes private practices fast to close is the same thing that makes them fragile to keep, and everything that makes health systems slow to close is the same thing that makes them durable once you're in. Neither side of that trade is free.
When to Start With Private Practices
Start with private practices when your product can prove its value without touching the EHR and without a security review — a single practice's word to sign is enough by itself. That's the signal that matters more than practice size or specialty: can one person say yes.
A few concrete markers make private practices the right first move:
- Your product works standalone. It doesn't need to read or write patient records to deliver value — scheduling, patient communication, billing follow-up, and staff workflow tools usually clear this bar.
- You need fast, real feedback. A short sales cycle means you can ship a change and see whether it moves a real buying decision within the same month, not the same fiscal year.
- You're pre-revenue or early-revenue. A handful of practice-level deals gets cash and case studies in the door while a health system deal would still be sitting in legal review.
- Your pricing is genuinely self-serve. If a practice manager can approve the spend without a budget line item or a CFO sign-off, you're within their authority — health-system pricing usually isn't.
The tradeoff is real, and it shows up as revenue instability more than as product risk. A practice that churns takes a meaningful slice of a small logo base with it, and a single-owner practice can disappear from your pipeline for reasons that have nothing to do with your product — a retirement, a merger into a larger group, a bad year. Build your early pricing and support model assuming some of that churn is coming regardless of what you do right.
When to Start With Health Systems
Start with health systems only when the product genuinely requires system-level scale or integration to work at all — not because the deal size is more attractive. If a private-practice version of your product would just be a smaller, worse copy of the real thing rather than a legitimately different offering, you don't have a private-practice option; you have one product, and it's built for one buyer.
That's true when any of the following hold:
- Value only appears at population scale. Tools built around cross-department analytics, care coordination across specialties, or population health management don't have anything meaningful to do inside a single practice's four walls.
- PHI handling at volume is core to the pitch. If your differentiation depends on aggregating data across many providers or a large patient panel, a solo practice can't generate enough volume to prove the case.
- Deep EHR integration is non-negotiable. A product that has to write back into an EHR's clinical workflows is signing up for the same security and IT review a health system requires — you don't avoid that review by starting smaller, you just delay it.
- You have the runway for a long sales cycle. A multi-quarter close with no revenue until it lands is a real cash-flow decision, not just a go-to-market one — model it before you commit to it as a strategy.
The upside that justifies all of that: one signed health system can be worth many private-practice deals combined, and it tends to stay signed once implemented. That's a legitimate reason to target one — but only if your runway and your product actually support the wait, not because the total contract value looks better on a slide.
Hybrid Paths — Land Small, Expand Up
Most healthcare startups that end up serving health systems didn't start there. They started inside private practices, built proof, and used that proof to move up — the beachhead-and-adjacent-segment pattern Crossing the Chasm describes: win one narrow market completely before using it as a base to enter the next.
A few versions of that path show up repeatedly:
- Land with independent practices in one specialty, then approach the health systems that acquire them. Health systems are steadily rolling up independent practices; a tool already embedded and trusted inside the practices they're acquiring has a case for staying, rather than being ripped out on day one.
- Sell to an independent physician association or physician group before a full health system. These groups sit between the two buyer types — bigger than a solo practice, without the full procurement machinery of a hospital system — and can be a genuine intermediate rung rather than a detour.
- Use private-practice case studies as the evidence a health system's clinical champion needs to sponsor a pilot. A committee that won't take a cold pitch will often take a warm one backed by named practices already using the product successfully.
The trap in this pattern is trying to run it backwards — building health-system-grade integration and compliance from day one "to be ready," before you have any evidence the product works for anyone. That's usually money and time spent on a buyer you can't close yet, at the expense of the buyer you could close this month. If you're still building the evidence case for which of these paths fits your specific product, How to Validate a B2B Healthcare SaaS Idea covers how to test buyer willingness-to-pay before you commit to either beachhead.
Key Takeaways
- Private practices are the default beachhead for any product that can prove its value without EHR integration or a security review — faster cycles, smaller checks, real feedback within weeks.
- Health systems are the right first move only when the product requires system-level scale — population-level data, deep EHR write-back, or value that doesn't exist inside a single practice's four walls.
- The five dimensions that actually differ are sales cycle, deal size, decision process, integration demands, and churn risk — and the trade-off runs one direction: fast-to-close buyers churn more, slow-to-close buyers stick longer.
- A single-owner practice churning is a business-model risk, not a product failure — build pricing and support expecting some of it.
- A multi-quarter health system sales cycle is a cash-flow decision as much as a go-to-market one; don't commit to it without the runway to survive the wait.
- The proven path up is land-then-expand — private-practice traction and named case studies are frequently the evidence a health system's internal champion needs to sponsor a pilot.
- Don't build health-system-grade compliance before you have any paying customer — it's easy to spend the runway that should have gone to proving the product works at all.
FAQ
Can a startup sell directly to a health system without any private practice customers first?
Yes, but only if the product genuinely requires system-level scale to work — otherwise a startup with no reference customers is asking a risk-averse buying committee to be the first proof point, which is a much harder sell than coming in with existing case studies already in hand.
How long does a health system sales cycle actually take?
Multiple quarters is typical once security review, legal, and procurement are involved, and a year or longer isn't unusual for a first deal with a new vendor. Budget for that timeline in your runway planning, not just your pipeline forecast.
Do private practices churn more than health systems?
Generally yes, once a health system deal is fully implemented — switching costs and multi-year contracts make an installed system sticky, while a single practice can leave over a price change, an ownership change, or simply deciding the tool isn't essential. Design your pricing to absorb some private-practice churn rather than assuming every logo stays for good.
Is it worth building EHR integration before I have any paying customers?
Usually not. Deep EHR integration is expensive to build and to maintain, and it only pays off once you're selling to buyers who require it. Prove the product works for a buyer who doesn't need that integration first, then build the integration when a real health-system deal depends on it.
For the fuller framework on testing willingness-to-pay and evidence before you commit to either buyer, see the complete guide to startup idea validation, which covers where a beachhead decision like this one fits alongside problem validation and market sizing.